Schedule 13G ownership disclosure

ONCOCYTE CORPORATION

Common Stock, no par value · CUSIP: 68235C107

Event date: 2024-12-26

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Patrick W. Smith

    Shares: 1,773,903.00 · Class: 10.5%

  • PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015

    Shares: 1,773,903.00 · Class: 10.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-24-052337
Form type
SCHEDULE 13G/A
Filer
Insight Molecular Diagnostics Inc.
CIK
CIK 1642380
Filed
Dec 27, 2024
Reporting period
Dec 26, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub